Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia - Real-world Evidence of LongevitY of Botulinum Toxin in Cervical Dystonia
Authors not listed
Merz Therapeutics GmbH · 2023
Abstract
The goal of this retrospective, international, multi-center chart abstraction is to learn about the long-term impact of product-specific immunogenicity-related factors in different botulinum neurotoxin type A formulations in patients suffering from cervical dystonia. The main question it aims to answer is:
Do complex-containing (CC) botulinum toxin formulations impact the long-term clinical outcome in cervical dystonia patients compared to a complex-free (CF) formulation?
Researchers will compare differences observed in years 2 and 7 between two toxin groups, i.e., botulinum neurotoxins type A containing complexing proteins (CC) and without complexing proteins (CF).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-13 MST
Cite this
APA
Anonymous. (2023). Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia - Real-world Evidence of LongevitY of Botulinum Toxin in Cervical Dystonia. <em>Merz Therapeutics GmbH</em>. https://clinicaltrials.gov/study/NCT05884528
Vancouver
Anonymous. Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia - Real-world Evidence of LongevitY of Botulinum Toxin in Cervical Dystonia. Merz Therapeutics GmbH. 2023.
BibTeX
@misc{anon2023Assess,
title = {Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia - Real-world Evidence of LongevitY of Botulinum Toxin in Cervical Dystonia},
author = {Anonymous},
journal = {Merz Therapeutics GmbH},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ophthalmology 2019
Open access · CC-BY
Macular Atrophy in Neovascular Age-Related Macular Degeneration
Trials 2026
Open access · CC-BY
Investigating the effect of intermittent fasting (time-restricted eating) with and without calorie restriction compared to calorie restriction on anthropometric parameters, depression score, and metabolic factors in patients with major depression disorder and obesity: a study protocol for a randomized controlled trial
Frontiers of Medicine 2013
Citation only
Telomeric impact of conventional chemotherapy
npj Aging and Mechanisms of Disease 2017
Open access · CC-BY
Health benefits of late-onset metformin treatment every other week in mice
Cochrane Database of Systematic Reviews 2023
Open access · OA
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
Trials 2026
Citation only